C.I. MEDICAL CO Ltd (3540)

Tokyo

Currency in JPY

921.0

+7.0(+0.77%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

915.0

928.0

52 wk Range

646.0

1,366.0

CI MEDICAL (3540) Income Statement & Profits

Assess the CI MEDICAL Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

37,393

41,205

42,891

45,628

67,493

Total Revenues Growth

aa.aa

+30%

+10.19%

+4.09%

+6.38%

+47.92%

Cost Of Revenues

aa.aa

26,100

29,600

31,218

33,633

46,205

Gross Profit

aa.aa

11,293

11,605

11,673

11,995

21,288

Gross Profit Growth

aa.aa

+45.66%

+2.76%

+0.59%

+2.76%

+77.47%

Gross Profit Margin %

aa.aa

30.2%

28.16%

27.22%

26.29%

31.54%

Other Operating Expenses, Total

aa.aa

6,590

7,081

7,681

9,004

18,793

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+16.58%	+7.45%	+8.47%	+17.22%	+108.72%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6,590	7,081	7,681	9,004	16,698
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

4,703

4,524

3,992

2,991

2,495

Operating Income Growth

aa.aa

+123.95%

-3.81%

-11.76%

-25.08%

-16.58%

EBIT Margin %

aa.aa

12.58%

10.98%

9.31%

6.56%

3.7%

Net Interest Expenses

aa.aa

-14

Net Interest Expenses Growth

aa.aa

-16.67%

-16%

+47.62%

-35.48%

-170%

Interest Expense, Total

aa.aa

-17

-61

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

118

139

EBT, Excl. Unusual Items

aa.aa

4,766

4,597

4,044

3,129

2,620

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-2

-27

-165

113

-48

EBT, Incl. Unusual Items

aa.aa

4,450

4,284

3,850

3,182

7,077

EBT, Incl. Unusual Items Growth

aa.aa

+107.17%

-3.73%

-10.13%

-17.35%

+122.41%

EBT, Incl. Unusual Items Margin

aa.aa

11.9%

10.4%

8.98%

6.97%

10.49%

Income Tax Expense

aa.aa

1,530

1,464

1,326

1,084

777

Net Income to Company

aa.aa

2,920

2,820

2,524

2,098

6,300

Minority Interest

aa.aa

-3

-16

-34

Net Income

aa.aa

2,920

2,820

2,521

2,082

6,266

Net Income Growth

aa.aa

+94.02%

-3.42%

-10.6%

-17.41%

+200.96%

Net Income Margin %

aa.aa

7.81%

6.84%

5.88%

4.56%

9.28%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

2,920

2,820

2,521

2,082

6,266

Basic EPS - Continuing Operations

aa.aa

58.4

56.4

50.43

41.64

125.32

Basic EPS - Continuing Operations Growth

aa.aa

+94.02%

-3.42%

-10.59%

-17.41%

+200.94%

Diluted EPS - Continuing Operations

aa.aa

58.4

56.4

50.43

41.64

125.32

Diluted EPS - Continuing Operations Growth

aa.aa

+94.02%

-3.42%

-10.59%

-17.41%

+200.94%

Basic Weighted Average Shares Outstanding

aa.aa

Diluted Weighted Average Shares Outstanding

aa.aa

Dividend Per Share

aa.aa

5.84

5.64

5.04

12.53

Dividend Per Share Growth

aa.aa

+93.96%

-3.42%

-10.6%

+148.41%

EBITDA

aa.aa

4,974

4,869

4,388

4,013

4,831

EBITDA Growth

aa.aa

+108.29%

-2.11%

-9.88%

-8.55%

+20.38%

EBITDA Margin %

aa.aa

13.3%

11.82%

10.23%

8.8%

7.16%

EBIT

aa.aa

4,703

4,524

3,992

2,991

2,495

* In Millions of JPY (except for per share items)

FTSE 100

8,786.46

+5.34

+0.06%

DAX

24,122.40

+86.29

+0.36%

Euro Stoxx 50

5,451.95

-2.70

-0.05%

S&P 500

5,844.55

-95.91

-1.61%

Nikkei 225

37,298.98

-230.51

-0.61%

Dow Jones

41,860.01

-817.23

-1.91%

FTSE 100 Futures

8,738.10

-58.9

-0.67%

Market Movers

Name	Last	Chg. %	Vol.
NatWest Group	519.40	+0.70%	57.62M
Rolls-Royce Holdings	824.40	+0.83%	44.00M
BP	362.25	-0.94%	39.69M
HSBC	884.60	-0.52%	19.72M
British American Tobacco	3,313.0	+0.76%	9.20M
Relx	4,129.00	+0.73%	4.37M
AstraZeneca	10,492.0	+0.71%	3.44M

Name	Last	Chg. %	Vol.
Inteliqo	0.03	+400.99%	0.00
Mila Resources	0.475	+63.79%	113.00M
Electric Guitar	0.11	+59.26%	149.08M
Revolution Beauty Group	7.09	+36.35%	4.55M
Gowin New Energy	0.0001	+33.33%	0.00
Cassel Capital	0.13	+30.00%	109.89M
Upland Resources	1.050	+27.27%	64.65M

Name	Last	Chg. %	Vol.
Tectonic Gold	0.002	-94.29%	0.00
Wolfspeed	1.29	-59.56%	5.16M
Accelerate Diagnostics	0.01	-46.51%	14.58K
ChallengerX plc	0.25	-37.50%	400.00K
Semperit AG Holding	14.54	-37.33%	2.00
Schweizerische Nationalbank	3,190.00	-30.04%	0.00
Palatin	0.10	-23.35%	8.27K

Trending Stocks

Name	Last	Chg. %	Vol.
Marks & Spencer	374.70	+1.93%	20.51M
Rolls-Royce Holdings	824.40	+0.83%	44.00M
JD Sports Fashion	83.12	-10.60%	49.48M
Lloyds Banking	77.98	-0.05%	181.14M
Vodafone Group PLC	78.300	+0.75%	111.42M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa	1,430.00	+42.14%	2,032.60
Aaaaa Aaaaaaaaaaa	362.25	+38.10%	500.27
Aaaaa Aaaaaa A Aaaa	158.80	+24.50%	197.71
Aaaaaaaaaaaa A	10,492.0	+23.55%	12,962.87
Aaaaaaa Aaaa	3,313.0	+22.22%	4,049.15
A Aaaaaaaaaaaaa	4,651.5	+20.95%	5,625.99
A Aaaaa	2,078.00	+18.60%	2,464.51

Name	Last	Upside	Fair Value
Aaaaaaaa	1,430.00	+42.14%	2,032.60
Aaaaa Aaaaaaaaaaa	362.25	+38.10%	500.27
Aaaaa Aaaaaa A Aaaa	158.80	+24.50%	197.71
Aaaaaaaaaaaa A	10,492.0	+23.55%	12,962.87
Aaaaaaa Aaaa	3,313.0	+22.22%	4,049.15
A Aaaaaaaaaaaaa	4,651.5	+20.95%	5,625.99
A Aaaaa	2,078.00	+18.60%	2,464.51

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

C.I. MEDICAL CO Ltd (3540)

CI MEDICAL (3540) Income Statement & Profits

Trending Stocks